TRIB
HEALTHCARETrinity Biotech Plc
$0.60+0.00 (+0.08%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TRIB Today?
No stock-specific AI insight has been generated for TRIB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.50$1.97
$0.60
Fundamentals
Market Cap$12M
P/E Ratio—
EPS$-2.00
Dividend Yield—
Dividend / Share—
ROE-19.1%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume52K
Avg Volume (10D)—
Shares Outstanding20.3M
TRIB News
20 articles- European Equities Traded in the US as American Depositary Receipts Start Week LowerYahoo Finance·May 4, 2026
- Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial OperationsYahoo Finance·May 1, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 24, 2026
- European Equities Traded in US as ADRs Ease in Thursday TradingYahoo Finance·Apr 23, 2026
- European Equities Traded in the US as American Depositary Receipts Sharply Higher in Friday TradingYahoo Finance·Apr 17, 2026
- European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday TradingYahoo Finance·Apr 15, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday TradingYahoo Finance·Apr 13, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday TradingYahoo Finance·Apr 7, 2026
- European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday TradingYahoo Finance·Mar 25, 2026
- Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer TestYahoo Finance·Mar 23, 2026
- European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday TradingYahoo Finance·Mar 19, 2026
- European Equities Traded in US as ADRs Fall in Wednesday TradingYahoo Finance·Mar 18, 2026
- Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s SyndromeYahoo Finance·Mar 18, 2026
- European Equities Traded in the US as American Depositary Receipts Higher TuesdayYahoo Finance·Mar 17, 2026
- Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column SystemYahoo Finance·Mar 12, 2026
- Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM ProgramYahoo Finance·Mar 11, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingYahoo Finance·Mar 10, 2026
- Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ PlatformYahoo Finance·Mar 10, 2026
All 20 articles loaded
Price Data
Open$0.60
Previous Close$0.60
Day High$0.63
Day Low$0.60
52 Week High$1.97
52 Week Low$0.50
52-Week Range
$0.50$1.97
$0.60
Fundamentals
Market Cap$12M
P/E Ratio—
EPS$-2.00
Dividend Yield—
Dividend / Share—
ROE-19.1%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume52K
Avg Volume (10D)—
Shares Outstanding20.3M
About Trinity Biotech Plc
Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—